Smith D J, Trantolo D J, King W F, Gusek E J, Fackler P H, Gresser J D, De Souza V L, Wise D L
Department of Immunology, Forsyth Dental Center, 140 The Fenway, Boston, MA 02115, USA.
Oral Microbiol Immunol. 2000 Apr;15(2):124-30. doi: 10.1034/j.1399-302x.2000.150209.x.
The effect of mucosal delivery of Streptococcus sobrinus glucosyltransferase (GTF) in bioadhesive poly (D,L-lactide-co-glycolide) (PLGA) microparticles on induction of salivary IgA and serum IgG antibody responses was measured in Sprague-Dawley rats. Preparations of GTF/PLGA/gelatin microparticles, or PLGA/gelatin microparticles or GTF in alum, were administered four times at weekly intervals by intranasal or intragastric routes. Two subcutaneous injections of GTF in PLGA/gelatin microparticles or in alum were given to separate groups of rats. Significant elevations in salivary IgA antibody levels to S. sobrinus GTF were observed only in the groups immunized intranasally 28 days after immunizations were begun. Five of six rats given the GTF microparticles intranasally had positive salivary IgA antibody responses to GTF, and the mean salivary IgA antibody level of this group was 30-fold higher than any other mucosally or systemically immunized group. Salivary IgA responses in the GTF-microparticle group remained significantly higher than all other mucosally immunized groups for at least 10 weeks after the primary immunization. All rats in this group demonstrated aspects of anamnesis following a more limited secondary course of intranasal administration. Intranasal administration of GTF in microparticles also induced a serum IgG response to GTF in some rats. After secondary intranasal GTF microparticle administration, several rats had sustained serum IgG antibody levels that were within the range of sera from rats subcutaneously injected with GTF in microparticles or in alum. Thus intranasal delivery of GTF-containing bioadhesive microparticles induced the highest and longest lasting salivary immune response of any mucosal or systemic route or vehicle tested and could be expected to be a useful method for induction of mucosal immunity.
在斯普拉格-道利大鼠中,测量了生物黏附性聚(D,L-丙交酯-共-乙交酯)(PLGA)微粒中变形链球菌葡糖基转移酶(GTF)经黏膜给药对唾液IgA和血清IgG抗体反应诱导的影响。GTF/PLGA/明胶微粒制剂、PLGA/明胶微粒制剂或明矾中的GTF,通过鼻内或胃内途径每周给药一次,共给药四次。给不同组的大鼠进行两次皮下注射PLGA/明胶微粒中的GTF或明矾中的GTF。仅在免疫开始28天后经鼻免疫的组中,观察到唾液中针对变形链球菌GTF的IgA抗体水平显著升高。六只经鼻给予GTF微粒的大鼠中有五只对GTF有阳性唾液IgA抗体反应,该组的平均唾液IgA抗体水平比任何其他经黏膜或全身免疫的组高30倍。在初次免疫后至少10周内,GTF微粒组的唾液IgA反应仍显著高于所有其他经黏膜免疫的组。该组所有大鼠在更有限的二次鼻内给药过程后均表现出回忆反应。鼻内给予微粒中的GTF在一些大鼠中也诱导了针对GTF的血清IgG反应。二次鼻内给予GTF微粒后,几只大鼠的血清IgG抗体水平持续维持在皮下注射微粒中的GTF或明矾中的GTF的大鼠血清范围内。因此,经鼻递送含GTF的生物黏附微粒诱导了所测试的任何黏膜或全身途径或载体中最高且持续时间最长的唾液免疫反应,有望成为诱导黏膜免疫的有用方法。